The Defense Security Cooperation Agency notified Congress�(link opens in PDF) on Monday of plans to conduct a Foreign Military "Sale" of technical and logistics support services for F/A-18 C/D fighter jets to the government of Kuwait.
According to the DSCA, contractors General Dynamics (NYSE: GD ) , Boeing (NYSE: BA ) , and Wyle Laboratories are in line to perform avionics software upgrades and engine component improvements and to sell ground support equipment, spare parts, technical documentation, and other "technical and logistics support services" to Kuwait for an estimated $200 million.
The DSCA justifies the "sale" by saying it will "contribute to the foreign policy and national security of the United States by helping to improve the security of a friendly country which has been, and continues to be, an important force for political stability and economic progress in the Middle East."
The DSCA further assures Congress that "the proposed sale of this support will not alter the basic military balance in the region," nor will there be any "adverse impact on U.S. defense readiness as a result of this proposed sale."
Top 10 Supermarket Stocks To Own Right Now: Sao Martinho SA (SMTO3)
Sao Martinho SA is a Brazil-based holding company primarily engaged in the sale and production of sugar and ethanol. It is engaged in the cultivation of sugar cane and production and sale of sugar, ethanol and other sugar cane products. The Company is also involved in the cogeneration of electricity and cattle breeding, as well as the provision of agricultural products. The Company produces hydrous ethanol, anhydrous ethanol, industrial ethanol, ribonucleic acid, fuel oil, yeast, sugar and sugarcane biogases, used to generate steam and electricity. Through its subsidiary Omtek, the Company produces ribonucleic acid (RNA) sodium salt, which is used in the pharmaceutical and food industries as a raw material and flavor enhancer. The Company operates through a numerous subsidiaries, including Vale do Mogi Empreendimentos Imobiliarios SA, SMA Industria Quimica SA, Usina Santa Luiza SA, Sao Martinho Energia SA and Santa Cruz SA, among others. Advisors' Opinion:- [By Ney Hayashi]
Sugar and ethanol producer Sao Martinho SA (SMTO3) fell 1.8 percent to 25.53 reais after posting a quarterly profit that missed analysts��estimates.
Top 10 Logistics Companies To Invest In Right Now: SanDisk Corporation(SNDK)
Sandisk Corporation designs, develops, and manufactures NAND flash memory storage solutions that are used in various consumer electronics products. The company offers removable cards under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; embedded products under the iNAND brand; universal serial bus (USB) flash drives under the Cruzer brand; digital media players under the Sansa brand; solid state drives under the Lightning brand; and wafers and memory components. Its removable card products are used in a range of consumer electronics devices, including mobile phones, digital cameras, gaming devices, and laptop computers; and embedded flash products are used in mobile phones, tablets, ultrabooks, eReaders, global positioning system devices, gaming systems, imaging devices, and computing platforms. The company also provides high-capacity storage solutions, such as solid-state drives that are used in lieu of hard disk drives. It offers its products to the m obile phone, consumer electronics, and computing end markets through original equipment manufacturers, distributors, and retail sales channels in the Americas, the Asia Pacific, Europe, the Middle East, Africa, and Japan. The company was formerly known as SunDisk Corporation and changed its name to SanDisk Corporation in August 1995. SanDisk Corporation was founded in 1988 and is headquartered in Milpitas, California.
Advisors' Opinion:- [By John Udovich]
Small cap storage stock Dot Hill Systems Corp (NASDAQ: HILL) is up 193.4% since the start of the year for a much better performance than its larger cap peers Western Digital Corp (NASDAQ: WDC) and SanDisk Corporation (NASDAQ: SNDK), which are 55.5% and 35.3%, respectively, since the start of the year. So why has this relatively unknown small cap storage stock been a better performer than its better known storage stock peers?
- [By Garrett Cook]
Fusion-io (NYSE: FIO) shares were also up, gaining 22..90 percent to $11.40 after SanDisk (NASDAQ: SNDK) announced its plans to buy Fusion-io for $11.25 per share in cash.
Top 10 Logistics Companies To Invest In Right Now: Helix Energy Solutions Group Inc (HLX)
Helix Energy Solutions Group, Inc.( Helix), incorporated on November 17,1983, is an international offshore energy company that provides specialty services to the offshore energy industry, with a focus on its growing well intervention and robotics operations. The Company had had two business segments: Contracting Services and Production Facilities. Its Contracting Services seek to provide services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economi regions. Its Production Facilities segment consists of its majority ownership of a dynamically positioned floating production vessel ( Helix Producer I or HP I). In June 2013, Helix Energy Solutions Group Inc closed the previously announced sale of its pipelay vessel, the Caesar, to Trevaskis Ltd.
In January 2012, it sold its oil and gas properties within the Main Pass area of the Gulf of Mexico. On September 26, 2012, the Company sold its pipelay vessel, Intrepid, to Stabbert Maritime Holdings, LLC. On February 6, 2013, it sold Energy Resource Technology GOM, Inc. (ERT), a former wholly-owned United States subsidiary that conducted its oil and gas operations in the Gulf of Mexico.
Contracting Services Operations
The Company provides services and methodologies which it believes are critical to developing offshore reservoirs and maximizing production economics. Its life of field services are segregated into four disciplines: well intervention, robotics, subsea construction and production facilities. It provides a full range of contracting services primarily in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions primarily in deepwater.
The Company's services include production, which includes inspection, repair and maintenance of production structures, trees, jumpers, risers, pipelines and subsea equipment, well intervention, life of field support and intervention engineering; reclamation and remediation services include pluggin! g and abandonment services, pipeline abandonment services and site inspections; installation of subsea pipelines, flowlines, control umbilicals, manifold assemblies and risers, pipelay and burial, installation and tie-in of riser and manifold assembly, commissioning, testing and inspection, and cable and umbilical lay and connection. It provides oil and natural gas processing services to oil and natural gas companies, primarily those operating in the deepwater of the Gulf of Mexico using its HP I vessel. The HP I is being utilized to process production from the Phoenix.
The Company engineers, manages and conducts well construction, intervention and asset retirement operations in water depths ranging from 200 to 10,000 feet. Three of its vessels serve as work platforms for well intervention services at costs that are typically significantly less than offshore drilling rigs. In the Gulf of Mexico, its multi-service semi-submersible vessel, the Q4000, has set a series of well intervention firsts in increasingly deeper water without the use of a traditional drilling rig. In August 2012, it acquired the Discoverer 534 drillship from a subsidiary of Transocean Ltd.
The Company operates remotely operated vehicles ( ROVs), trenchers and ROVDrills designed for offshore construction and well intervention services. As global marine construction support moves to deeper water. Its chartered vessels add value by supporting deployment of its ROVs. It provides its customers with vessel availability and schedule flexibility to meet the technological challenges of their subsea activities worldwide. Its robotics assets include 49 ROVs, four trencher systems and two ROVDrills. It operate in the Gulf of Mexico, North Sea, Asia Pacific and West Africa regions. It charters four vessels to support its robotics operations and it has engaged additional vessels on short-term (spot) charters as needed. In 2012, its robotics operations had 377 vessel utilization days and 16% of global revenues derived from! alternat! ive energy contracts. Subsea construction services include the use of umbilical lay and pipelay vessels and ROVs to develop fields in the deepwater.
The Company owns interests in two production facilities in hub locations where there is potential for subsea tieback activity. It has invested in two over-sized facilities that allow the operators of these fields to tie back without burdening the operator of the hub reservoir. It owns a 50% interest in Deepwater Gateway, which owns the Marco Polo TLP located in 4,300 feet of water in the Gulf of Mexico. It also owns a 20% interest in Independence Hub which owns the Independence Hub platform, a 105-foot deep draft, semi-submersible platform located in a water depth of 8,000 feet that serves as a regional hub for up to one billion cubic feet (Bcf) of natural gas production per day from multiple ultra-deepwater fields in the eastern Gulf of Mexico.
The Company competes with Oceaneering International, Inc., Saipem S.p.A., Fugro N.V., DOF ASA, Aker Solutions ASA, Subsea 7 S.A., Technip, McDermott International, Inc., Island Offshore and Edison Chouest Offshore Companies.
Advisors' Opinion:- [By David Smith]
Helix Energy Solutions Group (NYSE: HLX )
At $2.70 billion in market capitalization, Helix is equidistant between Flotek and Superior from a size perspective. The company operates through two segments: contracting services and production facilities. - [By GuruFocus]
Helix Energy Solutions Group Inc (HLX): PRESIDENT & CEO Owen E Kratz Bought 50,000 Shares PRESIDENT & CEO of Helix Energy Solutions Group Inc (HLX) Owen E Kratz bought 50,000 shares on 10/24/2013 at an average price of $24.03. Helix Energy Solutions Group Inc has a market cap of $2.54 billion; its shares were traded at around $24.03 with and P/S ratio of 2.96.
Top 10 Logistics Companies To Invest In Right Now: Alimera Sciences Inc.(ALIM)
Alimera Sciences, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the back of the eye or retina. The company is developing ILUVIEN, an intravitreal insert in phase-3 clinical trials for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN insert designed to be inserted into the patient?s eye to release a daily dose of fluocinolone acetonide over an anticipated period of 24 to 36 months. The company also conducts phase-2 clinical trials on ILUVIEN for the treatment of the dry form of age-related macular degeneration (AMD), the wet form of AMD, and retinal vein occlusion. In addition, it conducts testing on two classes of nicotinamide adenine dinucleotide phosphate oxidase inhibitors. Further, the company develops I LUVIEN inserter, a custom insertion system for ILUVIEN. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia.
Advisors' Opinion:- [By John Kell]
Specialty pharmaceutical firm pSivida Corp.(PSDV) said the U.S. Food and Drug Administration didn’t approve a treatment for an eye disease found in patients with diabetes. The company’s stock tumbled 47% to $2 premarket, while shares of Alimera Sciences Inc.(ALIM) were down 39% to $1.66, as the treatment is licensed and sold by Alimera in other markets.
Top 10 Logistics Companies To Invest In Right Now: PIMCO Income Strategy Fund II(PFN)
PIMCO Income Strategy Fund II is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in the fixed income markets of the United States. It invests in securities of companies operating across the diversified sectors. The fund invests in floating-rate debt instruments primarily high-yield senior floating-rate loans. It employs fundamental analysis with top-down approach to create its portfolio. The fund conducts an in-house research to make its investments. It was formerly known as PIMCO Floating Rate Strategy Fund. PIMCO Income Strategy Fund II was formed on June 30, 2004 and is domiciled in the United States.
Advisors' Opinion:- [By John Gerard Lewis]
Pimco Income Strategy II Fund (PFN) - 15% Allocation
Pimco has a mind-boggling number of fixed-income offerings, all, at least by reputation, influenced by the philosophies of legendary "bond king" Bill Gross. PFN is the pick here, though, because it yields about 9.5% while selling at roughly 2% below NAV. And it's personally managed by Mr. Gross.
Top 10 Logistics Companies To Invest In Right Now: Tetraphase Pharmaceuticals Inc (TTPH)
Tetraphase Pharmaceuticals, Inc., incorporated on July 7, 2006, is a clinical stage biopharmaceutical company. The Company�� product candidate, eravacycline, is a fully synthetic tetracycline derivative that the Company are developing as a broad-spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multi-drug resistant infections, including multi-drug resistant Gram-negative infections. The Company�� frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is required. During the year ended December 31, 2012, completed a Phase 2 clinical trial of eravacycline with intravenous administration for the treatment of patients with complicated intra-abdominal infections, or cIAI, and are finalizing its pivotal Phase 3 program for eravacycline. In 2012, in vitro experiments, eravacycline has demonstrated the ability to cover a variety of multi-drug resistant Gram-negative, Gram-positive, anaerobic and atypical bacteria, including multi-drug resistant Klebsiella pneumoniae, the species of Gram-negative bacteria that killed seven patients at the Clinical Center of the National Institutes of Health.
Gram-positive bacteria that have developed resistance to existing drugs include: Streptococcus pneumoniae that cause pneumonia, ear infections, bloodstream infections and meningitis; Staphylococcus aureus that cause skin, bone, lung and bloodstream infections, and Enterococci that are responsible for infections transmitted in healthcare settings. Gram-negative bacteria that have developed resistance to existing drugs include: Escherichia coli that cause urinary tract, skin and bloodstream infections; Salmonella and Escherichia coli that cause foodborne infections, and Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella spp.
In addition, other antibiotics that have been used as first-line empiric monothe! rapies, such as Levaquin, piperacillin/tazobactam, which is marketed by Pfizer as Zosyn, carbapenems, such as Merrem, and imipenem/cilastatin, which is marketed by Merck as Primaxin, have seen their utility as first-line empiric monotherapies diminished as the number of bacterial strains resistant to these therapies has increased. In addition to developing an intravenous formulation of eravacycline, the Company is also developing an oral formulation. A number of previous tetracyclines have been available in both intravenous and oral dosage forms. Infections that are resistant to existing oral drugs are increasingly common, and the Company believe that an intravenous-to-oral step-down therapy in which patients are started on the intravenous formulation of eravacycline and then stepped down to an oral formulation of eravacycline could reduce the length of a patient�� hospital stay or help avoid hospital admission altogether, lowering the overall cost of care for these patients.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a near-term breakout trade is Tetraphase Pharmaceuticals (TTPH), which using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections. This stock is off to a strong start in 2013, with shares up 19.4%.
If you take a look at the chart for Tetraphase Pharmaceuticals, you'll notice that this stock has just started to trend back above its 50-day moving average of $7.76 a share with decent upside volume flows. That move is quickly pushing shares of TTPH within range of breaking out above some key near-term overhead resistance levels that have acted as a ceiling for the stock for the last three months.
Market players should now look for long-biased trades in TTPH if it manages to break out above some near-term overhead resistance levels at $8.30 to $8.40 a share and then once it takes out more resistance at $8.50 to $9 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 62,234 shares. If that breakout triggers soon, then TTPH will set up to re-test or possibly take out its all-time high at $9.66 a share. Any high-volume move above that level will then push TTPH into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $12 to $13 a share.
Traders can look to buy TTPH off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.76 a share, or below more key near-term support levels at $7.37 to $7.02 a share. One can also buy TTPH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Logistics Companies To Invest In Right Now: Cleveland BioLabs Inc.(CBLI)
Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultan eously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.
Advisors' Opinion:- [By Lisa Levin]
Cleveland BioLabs (NASDAQ: CBLI) shares tumbled 34.67% to touch a new 52-week low of $0.74 as the company reported that BARDA has terminated negotiations related to its proposal for further development of Entolimod.
No comments:
Post a Comment